These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16267227)

  • 1. Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains.
    Eisensamer B; Uhr M; Meyr S; Gimpl G; Deiml T; Rammes G; Lambert JJ; Zieglgänsberger W; Holsboer F; Rupprecht R
    J Neurosci; 2005 Nov; 25(44):10198-206. PubMed ID: 16267227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of ligand-gated ion channels as a novel pharmacological principle.
    Nothdurfter C; Tanasic S; Rammes G; Rupprecht R
    Pharmacopsychiatry; 2011 May; 44 Suppl 1():S27-34. PubMed ID: 21544743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants.
    Nothdurfter C; Tanasic S; Di Benedetto B; Rammes G; Wagner EM; Kirmeier T; Ganal V; Kessler JS; Rein T; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2010 Jun; 35(7):1510-9. PubMed ID: 20200506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
    Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
    Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
    Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
    Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
    Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
    Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
    Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
    Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
    Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
    Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors.
    Squires RF; Saederup E
    Neurochem Res; 1999 May; 24(5):659-67. PubMed ID: 10344595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.
    Barann M; Göthert M; Brüss M; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):234-41. PubMed ID: 10543423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants.
    Levy AD; Van de Kar LD
    Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
    Gumilar F; Bouzat C
    Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
    Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antidepressant mirtazapine inhibits 5-hydroxytryptamine3 receptor currents in NCB-20 cells.
    Park YS; Oh H; Sung KW
    J Pharmacol Sci; 2023 Feb; 151(2):63-71. PubMed ID: 36707180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.
    Dukat M; Alix K; Worsham J; Khatri S; Schulte MK
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5945-8. PubMed ID: 24035337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT3 receptor as a therapeutic target.
    Thompson AJ; Lummis SC
    Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.